R&D News | pharmaphorum

News

Pair of R&D updates bolster GSK ahead of investor meeting

GlaxoSmithKline (GSK) has reported encouraging data for its COVID-19 antibody sotrovimab, and an alliance with Halozyme to develop a new generation of long-acting HIV drugs, as it prepares

News

New hybrid healthcare agency Stirred launches

Healthcare communications specialists Jo Spadaccino and Stuart Hehir have launched a new agency named Stirred which will offer communications, marketing and creative consul

News

White House pledges $3 billion war chest for COVID antiviral...

The Biden Administration has said it will allocate $3 billion of its pandemic rescue plan to the development of a new generation of antiviral therapies for COVID-19, as well as future viral

News

Concept of memory loss and brain aging due to dementia and alzheimer's disease as a medical icon with fall trees shaped as a human head losing leaves with 3D illustration elements.

Biogen abandons tau antibody for Alzheimer's after phase 2 m...

Biogen has four other Alzheimer's candidates in its clinical pipeline behind recently-approved Aduhelm, but one of them – anti-tau antibody gosuranemab – has just been canned.

News

CureVac hit hard as its COVID jab fails to make the grade

CureVac has just had a harsh reminder of the perilous nature of drug development, after reporting that its mRNA-based COVID-19 vaccine was just 47% effective in its 40,000-subject phase 3 t

News

Sage/Biogen's zuranolone works in depression, but maybe not ...

Sage Therapeutics and Biogen's antidepressant candidate zuranolone has hit its objectives in a phase 3 trial, but a falloff in efficacy over time has raised concerns about the commercial po

Pair of R&D updates bolster GSK ahead of investor meeting

New hybrid healthcare agency Stirred launches

White House pledges $3 billion war chest for COVID antiviral...

Biogen abandons tau antibody for Alzheimer's after phase 2 m...

CureVac hit hard as its COVID jab fails to make the grade

Sage/Biogen's zuranolone works in depression, but maybe not ...

Five indications added to Pharmacy First prescribing scheme

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks